Lipocine Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q3 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Lipocine Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q3 2011 to Q3 2024.
  • Lipocine Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.22M, a 66.6% increase year-over-year.
  • Lipocine Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$4.06M, a 75.1% increase year-over-year.
  • Lipocine Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$16.4M, a 52% decline from 2022.
  • Lipocine Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$10.8M, a 1596% decline from 2021.
  • Lipocine Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$634K, a 97% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4.06M -$2.22M +$4.43M +66.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$8.49M -$3.07M +$480K +13.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$8.97M $3.51M +$7.38M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$16.4M -$2.28M -$52.3K -2.35% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$16.3M -$6.65M -$4.24M -176% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$12.1M -$3.55M -$917K -34.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$11.1M -$3.87M -$382K -11% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$10.8M -$2.23M -$14.9M -118% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 $4.1M -$2.41M +$672K +21.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $3.42M -$2.63M +$4.18M +61.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$754K -$3.49M -$120K -3.55% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$634K $12.6M +$17.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-10
Q3 2021 -$17.8M -$3.08M +$1.23M +28.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$19M -$6.81M -$439K -6.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$18.6M -$3.37M +$2.4M +41.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$21M -$4.51M -$1.22M -37% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-09
Q3 2020 -$19.7M -$4.31M -$1.25M -40.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$18.5M -$6.37M -$2.94M -85.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$15.6M -$5.77M -$2.55M -79% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$13M -$3.29M -$66.6K -2.07% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 -$12.9M -$3.06M -$601K -24.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$12.3M -$3.43M -$175K -5.38% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$12.2M -$3.22M -$505K -18.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$11.7M -$3.23M +$2.11M +39.5% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-06
Q3 2018 -$13.8M -$2.46M +$2.24M +47.7% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$16M -$3.26M +$2.83M +46.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 -$18.8M -$2.72M +$2.14M +44% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$21M -$5.33M -$2.37M -79.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$18.6M -$4.7M -$1.46M -45.3% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-06
Q2 2017 -$17.2M -$6.09M -$330K -5.72% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-06
Q1 2017 -$16.8M -$4.86M +$2.15M +30.6% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-06
Q4 2016 -$19M -$2.97M +$1.67M +36% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-12
Q3 2016 -$20.6M -$3.24M +$3.14M +49.2% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-12
Q2 2016 -$23.8M -$5.76M -$1.51M -35.6% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-12
Q1 2016 -$22.3M -$7.01M -$4.05M -137% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-12
Q4 2015 -$18.2M -$4.63M -$594K -14.7% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-06
Q3 2015 -$17.6M -$6.37M -$2.28M -55.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-06
Q2 2015 -$15.3M -$4.25M +$2.73M +39.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-06
Q1 2015 -$18.1M -$2.96M +$2.31M +43.9% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-06
Q4 2014 -$20.4M -$4.04M +$350K +7.98% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-06
Q3 2014 -$20.7M -$4.09M -$619K -17.8% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$20.1M -$6.97M -$5.6M -408% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$14.5M -$5.27M -$3.92M -290% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$10.6M -$4.39M -$9.41M -187% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$1.18M -$3.48M -$2.46M -243% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 $1.28M -$1.37M -$1.31M -2142% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 $2.6M -$1.35M -$1.29M -2108% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
Q4 2012 $3.89M $5.02M +$5.03M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$1.14M -$1.01M -$1.01M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-13
Q2 2012 -$128K -$61.2K Apr 1, 2012 Jun 30, 2012 10-Q 2012-07-18
Q1 2012 -$61.2K Jan 1, 2012 Mar 31, 2012 10-Q 2013-07-09
Q4 2011 -$5.16K* Oct 13, 2011 Dec 31, 2011 10-K 2013-02-26
Q3 2011 $0 Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.